Format

Send to

Choose Destination
Bone Marrow Transplant. 2002 May;29(10):871-2.

Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab.

Author information

1
Department of Pediatrics, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Abstract

Here, we report a case of paediatric beta-thalassaemia major patient who underwent unrelated T cell-non- depleted bone marrow transplantation and developed a complication of autoimmune haemolytic anaemia (AIHA) refractory to corticosteroid and intravenous immunoglobulin therapy. After this child received two doses (375 mg/m2/dose) of rituximab (anti-CD20 monoclonal antibody), his AIHA was resolved.

PMID:
12058238
DOI:
10.1038/sj.bmt.1703551
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center